Takeda Pharmaceuticals (United States)

Takeda Pharmaceutical Company is a Japanese multinational and one of the world’s largest biopharmaceutical companies. The company focuses on gastroenterology, rare diseases, oncology, and neuroscience. Key products include Entyvio (vedolizumab) for inflammatory bowel disease, Vyvanse for ADHD, multiple rare disease treatments from former Shire, and oncology products including Ninlaro and Alunbrig. Takeda’s global research advances treatments for complex diseases.